Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Molecular Cancer|December 2, 2025
Multi-omic profiling provides insights into the heterogeneity, microenvironmental features, and biomarker landscape of small-cell lung cancerMingchao Xie, Miljenka Vuko, Shashank Saran, et al.Cancer Research|June 11, 2015
Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized ImmunotherapyPauline Maby, David Tougeron, Mohamad Hamieh, et al.Frontiers in Immunology|October 8, 2024
Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoringJulie Berthe, Pawan Poudel, Felix J Segerer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2025
AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid TumorsLillian L Siu, Sophie Postel-Vinay, Rafael Villanueva-Vázquez, et al.Cancer Research Communications|December 18, 2025
Characterisation of the immunogenomic landscape of ovarian cancer uncovers a distinct subset of endometroid tumours associated with high CST2 expression and a favourable prognosisJames Boyle, Jan Zaucha, Felicia Ng, et al.British Journal of Cancer|October 19, 2021
Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage responseSophie E Willis, Claudia Winkler, Martine P Roudier, et al.The Lancet. Oncology|August 11, 2020
Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket studySusan M Domchek, Sophie Postel-Vinay, Seock-Ah Im, et al.Immunity|March 17, 2016
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite InstabilityBernhard Mlecnik, Gabriela Bindea, Helen K Angell, et al.The Journal of Pathology|October 15, 2013
Towards the introduction of the 'Immunoscore' in the classification of malignant tumoursJérôme Galon, Bernhard Mlecnik, Gabriela Bindea, et al.Journal of Translational Medicine|October 5, 2012
Cancer classification using the Immunoscore: a worldwide task forceJérôme Galon, Franck Pagès, Francesco M Marincola, et al.Pageof 3